Raia Drogasil (OTCMKTS:RADLY) Hits New 52-Week Low – What’s Next?

Raia Drogasil S.A. (OTCMKTS:RADLY)’s stock price hit a new 52-week low during trading on Monday. The company traded as low as $2.88 and last traded at $2.9480, with a volume of 2,068 shares trading hands. The stock had previously closed at $4.16.

Analyst Upgrades and Downgrades

Separately, Jefferies Financial Group upgraded Raia Drogasil to a “buy” rating and set a $5.20 target price on the stock in a research note on Sunday, October 18th. One equities research analyst has rated the stock with a Buy rating and one has assigned a Hold rating to the company’s stock. Based on data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average target price of $5.20.

Raia Drogasil Stock Down 27.4%

The company has a current ratio of 1.41, a quick ratio of 0.58 and a debt-to-equity ratio of 0.99. The firm has a 50 day moving average price of $3.81 and a 200-day moving average price of $3.84. The firm has a market cap of $3.95 billion and a price-to-earnings ratio of 20.00.

Raia Drogasil (OTCMKTS:RADLY) last issued its quarterly earnings data on Tuesday, August 4th. The company reported $0.05 earnings per share (EPS) for the quarter, meeting the consensus estimate of $0.05. The business had revenue of $2.17 billion for the quarter, compared to the consensus estimate of $2.32 billion. Raia Drogasil had a return on equity of 20.12% and a net margin of 2.99%. On average, equities analysts forecast that Raia Drogasil S.A. will post 0.17 EPS for the current year.

Raia Drogasil Company Profile

Raia Drogasil, now operating under the name RD Saúde, is a Brazilian healthcare and pharmacy retail company. It operates a network of pharmacies offering prescription medicines, over-the-counter drugs, vitamins, personal care products, beauty items and other health-related merchandise.

The company also provides digital purchasing and delivery services through its online channels, supporting customers with prescription fulfillment, health products and related services. Its operations include pharmacy-based healthcare initiatives designed to complement its retail business and improve access to everyday healthcare.

RD Saúde was created in 2011 through the merger of Drogasil and Droga Raia, two established Brazilian pharmacy chains.